Adverse drug reactions of antidepressants and antipsychotics: Experience, knowledge and attitudes among Norwegian psychiatrists

Nordic Journal of Psychiatry

Volumn 60, Issue 3, 2006, Pages 227-233

  Castberg, Ingrid ^a,b   Reimers, Arne ^a,b   Sandvik, Pål ^a   Aamo, Trond O ^a   Spigset, Olav ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Adverse drug reaction reporting system; Adverse drug reactions; Antidepressants; Antipsychotics; Attitude of health personnel

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; DOPAMINE RECEPTOR; DRUG RECEPTOR; HISTAMINE RECEPTOR; MIRTAZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGITATION; AGRANULOCYTOSIS; AKATHISIA; ANORGASMIA; ARTICLE; BLURRED VISION; BODY WEIGHT DISORDER; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CONSTIPATION; CONTROLLED STUDY; DISORIENTATION; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG POTENCY; DRUG SURVEILLANCE PROGRAM; DYSTONIA; EJACULATION DISORDER; FEMALE; GASTROINTESTINAL SYMPTOM; HEALTH PERSONNEL ATTITUDE; HEART ARRHYTHMIA; HUMAN; HYPERPROLACTINEMIA; HYPERTENSION; HYPOTENSION; IMPOTENCE; INSOMNIA; MALE; NAUSEA; NORWAY; PARKINSONISM; PERSONAL EXPERIENCE; PHOTOSENSITIVITY; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; PSYCHIATRIST; QUESTIONNAIRE; RECEPTOR BLOCKING; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SWEATING; TACHYCARDIA; TARDIVE DYSKINESIA; TREMOR; URINE RETENTION; WEIGHT GAIN; XEROSTOMIA;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; DEMOGRAPHY; DEPRESSIVE DISORDER, MAJOR; DRUG MONITORING; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; NORWAY; QUESTIONNAIRES;

EID: 33744804598     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.1080/08039480600636494     Document Type: Article

References (24)

1. Weiner, J and Shumacher, GE. (1976) Psychotropic drug therapy knowledge of health care practitioners Am J Hosp Pharm, 33, pp. 237-41.
2. Gottlieb, RM and Nappi, T and Strain, JJ. (1978) The physician's knowledge of psychotropic drugs: Preliminary results Am J Psychiatry, 135, pp. 29-32.
3. Petersen, T and Dording, C and Neault, NB and Kornbluh, R and Alpert, JE and Nierenberg, AA and et al (2002) A survey of prescribing patterns in the treatment of depression Prog Neuropsychopharmacol Biol Psychiatry, 26, pp. 177-87.
4. Hu, XH and Bull, SA and Hunkeler, EM and Ming, E and Lee, JY and Fireman, B and et al (2004) Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: Patient report versus physician estimate J Clin Psychiatry, 65, pp. 959-65.
5. Wiholm, B-E and Olsson, S and Moore, N and Wood, S.(1994) Spontaneous reporting systems outside the United States. In Pharmacoepidemiology2nd edition. (pp. 139-55). Chichester: John Wiley & Sons.
6. Bäckström, M and Mjörndal, T and Dahlqvist, R. (2004) Under-reporting of serious drug reactions in Sweden Pharmacoepidemiol Drug Saf, 3, pp. 483-7.
7. Eland, IA and Belton, KJ and van Grootheest, AC and Meiners, AP and Rawlins, MD and Stricker, BH. (1999) Attitudinal survey of voluntary reporting of adverse drug reactions Br J Clin Pharmacol, 48, pp. 623-7.
8. Tisonova, J and Szalayova, A and Kriska, M and Gibala, P and Foltan, V. (2004) Factors influencing the spontaneous reporting of adverse drug reactions - The experience of the Slovak Republic Pharmacoepidemiol Drug Saf, 13, pp. 333-7.
9. Tubert-Bitter, P and Haramburu, F and Begaud, B and Chaslerie, A and Abraham, E and Hagry, C. (1998) Spontaneous reporting of adverse drug reactions: Who reports and what? Pharmacoepidemiol Drug Saf, 7, pp. 323-9.
10. BeltonKJ and The European Pharmacovigilance Research Group. Attitude survey of adverse drug reactions reporting by health care professionals across the European Union. Eur J Clin Pharmacol 1997;52:423-7.
11. Hasford, J and Goettler, M and Munter, KH and Müller-Oerlinghausen, B. (2002) Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions J Clin Epidemiol, 55, pp. 945-50.
12. Drug Consumption in Norway 1998-2002. Nasjonalt folkehelseinstitutt (Norwegian Institute of Public Health), Oslo; 2003.
13. Schafer, H. (1997) Post-approval drug research: Objectives and methods Pharmacopsychiatry, 30 Suppl. 1, pp. 4-8.
14. Bull, SA and Hunkeler, EM and Lee, JY and Rowland, CR and Williamson, TE and Schwab, JR and et al (2002) Discontinuing or switching selective serotonin reuptake inhibitors Ann Pharmacother, 36, pp. 578-84.
15. Geddes, J and Freemantle, N and Harrison, P and Bebbington, P. (2000) Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis BMJ, 321, pp. 1371-6.
16. Bäckström, M and Mjörndal, T and Dahlqvist, R and Nordkvist-Olsson, T. (2000) Attitudes to reporting adverse drug reactions in Northern Sweden Eur J Clin Pharmacol, 56, pp. 729-32.
17. Eldholm, RS and Bergheim, TS and Slørdal, L and Spigset, O. (2003) Hvilken informasjon gis om bivirkninger av nye legemidler? Tidsskr Nor Laegeforen, 123, pp. 2414-7.
18. Song, F and Freemantle, N and Sheldon, TA and House, A and Watson, P and Long, A and et al (1993) Selective serotonin reuptake inhibitors: Meta-analysis of efficacy and tolerability BMJ, 306, pp. 683-7.
19. Montgomery, SA and Henry, J and McDonald, G and Dinan, T and Lader, M and Hindmarch, I and et al (1994) Selective serotonin reuptake inhibitors: Meta-analysis of discontinuation rates Int Clin Psychopharmacol, 9, pp. 47-53.
20. Chakos, M and Lieberman, J and Hoffmann, E and Bradford, D and Sheitman, B. (2001) Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: A review and meta-analysis of randomized trials Am J Psychiatry, 158, pp. 518-26.
21. Leucht, S and Wahlbeck, K and Hamann, J and Kissling, W. (2003) New generation antipsychotics versus low-potency conventional antipsychotics: A systematic review and meta-analysis Lancet, 361, pp. 1581-9.
22. http://www.lovdata.no/for/sf/hd/td-19991222-1559-035.html#11-7
23. Belton, KJ and Lewis, SC and Payne, S and Rawlins, MD and Wood, SM. (1995) Attitudinal survey of adverse drug reactions reporting by medical practitioners in the United Kingdom Br J Clin Pharmacol, 39, pp. 223-6.
24. Stahl, SM.(2000) Antipsychotic agents. In Stahl SM. Essential psychopharmacology2nd edition. (pp. 401-58). Cambridge: Cambridge University Press.